NewAmsterdam Pharma Company N.V. - NAMS

About Gravity Analytica
Recent News
- 03.10.2025 - Leerink Partners Global Healthcare Conference 2025
- 03.10.2025 - Leerink Partners Global Healthcare Conference 2025
- 03.04.2025 - TD Cowen 45th Annual Healthcare Conference
- 03.04.2025 - TD Cowen 45th Annual Healthcare Conference
- 02.26.2025 - NewAmsterdam Pharma Reports Full Year 2024 Financial Results and Provides Corporate Update
- 02.26.2025 - NewAmsterdam Pharma Reports Full Year 2024 Financial Results and Provides Corporate Update
- 02.25.2025 - NewAmsterdam Pharma to Participate at Upcoming Investor Conferences in March
- 02.25.2025 - NewAmsterdam Pharma to Participate at Upcoming Investor Conferences in March
- 02.07.2025 - NewAmsterdam Pharma Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- 02.07.2025 - NewAmsterdam Pharma Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Recent Filings
- 02.26.2025 - 10-K Annual report [Section 13 and 15(d), not S-K Item 405]
- 02.26.2025 - EX-99.1 EX-99.1
- 02.26.2025 - 8-K Current report
- 02.20.2025 - 4 Statement of changes in beneficial ownership of securities
- 02.14.2025 - SCHEDULE 13G/A Statement of Beneficial Ownership by Certain Investors
- 02.14.2025 - SCHEDULE 13G/A Statement of Beneficial Ownership by Certain Investors
- 01.31.2025 - 4 Statement of changes in beneficial ownership of securities